There are 413 resources available
55P - Clinicopathological and molecular changes induced by neoadjuvant therapy (NAT) in hormone receptor-positive (HR+)/HER2-low vs. HER2 0 breast cancer (BC)
Presenter: Francesco Schettini
Session: Poster viewing and lunch
56P - Association between HER2 expression level and prognosis using RT-PCR in HER2-low breast cancer
Presenter: Saeko Nakagawa
Session: Poster viewing and lunch
57P - Clinicopathologic Landscape of High Risk Early Stage HER2-Low Breast Cancer
Presenter: Rebecca Nashed
Session: Poster viewing and lunch
58P - Quantitative indicators of TREC and KREC excision rings in breast cancer.
Presenter: Alexander Sultanbaev
Session: Poster viewing and lunch
59P - Tumor cells-adipocytes interactions are associated with poor disease outcome in invasive lobular carcinoma
Presenter: Matteo Serra
Session: Poster viewing and lunch
60P - Deep learning-based digital pathology for risk stratification of atypical ductal hyperplasia/ductal carcinoma in situ
Presenter: Chung-yen Huang
Session: Poster viewing and lunch
61P - Genomic risk and gene expression-based inference of anti-cancer drugs vulnerability in early breast cancer
Presenter: Alexandre De Nonneville
Session: Poster viewing and lunch
62P - KI67 in ER+HER2negative pure invasive lobular breast carcinoma (ILC). What’s the best Ki67 threshold to differentiate prognosis?
Presenter: Meritxell Bellet Ezquerra
Session: Poster viewing and lunch
63P - Ki67 values and MammaPrint (MP) genomic risk in Early Breast Cancer: Correlation by ductal vs lobular histology
Presenter: Esther Zamora
Session: Poster viewing and lunch
64P - Baseline characteristics associated with Ki67 drop after neoadjuvant endocrine therapy in patients with HR+/HER2- early breast cancer: a systematic review
Presenter: Diogo Martins Branco
Session: Poster viewing and lunch